7 Results for "

viral cellular entry

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "viral cellular entry" in MCE Product Catalog:

Cat. No.: HY-108447
CAS No.: 443776-49-6
Purity:  ≥99.0%
Research Areas:  

Infection Cancer

BC-11 hydrobromide is a selective TMPRSS2 inhibitor (TMPRSS2 is a key host cellular factor for viral entry and SARS-CoV-2 pathogenesis), and a selective urokinase (uPA) inhibitor (IC50=8.2 μM). BC-11 hydrobromide is cytotoxic to triple-negative MDA-MB231 breast cancer cells. BC-11 hydrobromide is used in research on viral infections and cancer .
loading...
    loading...
Cat. No.: HY-161844
CAS No.: 1794091-10-3
Target:  

SARS-CoV Dengue Virus

Research Areas:  

Infection

Virapinib is a macropinocytosis inhibitor with antiviral activity. Virapinib exhibits broad-spectrum antiviral activity against SARS-CoV-2, monkeypox virus, tick-borne encephalitis virus, and Ebola pseudotyped vesicular stomatitis virus, and it enhances Dengue Virus infection. Virapinib blocks viral entry by inhibiting macropinocytosis, reduces syncytium formation in SARS-CoV-2-infected cells, and impairs cellular entry of SARS-CoV-2 variants. Virapinib upregulates the expression of genes related to sterol biosynthesis. Virapinib can be used in studies related to COVID-19, monkeypox, tick-borne encephalitis, and Ebola virus infection .
loading...
    loading...
Cat. No.: HY-105086
CAS No.: 150332-35-7
Synonyms: CP148623
Target:  

SARS-CoV

Research Areas:  

Infection Metabolic Disease

Pamaqueside (CP148623) is a cholesterol absorption inhibitor and a potent binder of the SARS-CoV-2 receptor-binding domain (RBD), which may inhibit viral cellular entry. Pamaqueside can be utilized in metabolic and antiviral research .
loading...
    loading...
Cat. No.: HY-P10974
Target:  

HCV Enterovirus

Research Areas:  

Infection

La peptide (LAP) is an internal ribosome entry site (IRES) inhibitor. La peptide efficiently enters cells, blocks binding of cellular transacting factors to viral IRES, followed by inhibiting IRES-mediated translation. La peptide can be used for RNA viruses research, such as hepatitis C (HCV) and poliovirus (PV) .
loading...
    loading...
Cat. No.: HY-P991054
CAS No.: 1422526-93-9

Research Areas:  

Infection

CR-8020 is a broadly neutralizing antibody targeting the stem region of influenza A virus hemagglutinin (HA), with IC50 values of 0.06 nM or 3.36 nM. CR-8020 mediates antibody-dependent cellular cytotoxicity by activating Fcγ receptors. CR-8020 blocks viral fusion and entry. CR-8020 protects mice from lethal influenza A virus challenge. CR-8020 can be used in research related to influenza A virus infections (H3N2 and H7N9) .
loading...
    loading...
Cat. No.: HY-182341
CAS No.: 1261156-82-4
Target:  

Drug Derivative

Research Areas:  

Infection

APD-209 is a sialic acid conjugate with a PEG4 polar linker and a PDA non-polar tail. APD-209 aggregates adenovirus type 37 particles, blocks the binding of viral particles to human corneal epithelial cells, and inhibits cellular entry of adenovirus type 37. APD-209 can be used for the research of epidemic keratoconjunctivitis .
loading...
    loading...
Cat. No.: HY-187788
CAS No.: 2230674-01-6
Target:  

SARS-CoV

Research Areas:  

Infection

N-0385 is an antiviral agent active against SARS-CoV-2 and its Omicron subvariants. N-0385 acts on factors such as TMPRSS2 to block viral entry, reduce infection, regulate metabolism and inhibit inflammatory responses. N-0385 reduces SARS-CoV-2-induced mortality, weight loss, pulmonary pathological changes and cellular damage in animal models. N-0385 can be used in research related to coronavirus infections .
loading...
    loading...